SCHEMBL13545872

SCHEMBL13545872

COC(=O)c1ccccc1CNC(=O)c1[nH]nc2c1CCCC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.45
▸ ADORA2A P29274 1/20 0.44
▸ PARP1 P09874 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ TP53 P04637 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ KLKB1 P03952 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ NR4A1 P22736 1/20 0.39
▸ APEX1 P27695 1/20 0.39
▸ PTPN7 P35236 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13545861 0.85 HPGD (0.50) MAPK1ALDH1A1TP53KDM4EHPGD
SCHEMBL13545865 0.82 TP53 (0.49) MAPK1ALDH1A1TP53L3MBTL1NPC1
SCHEMBL13545776 0.76 ALDH1A1 (0.68) ALDH1A1HSD17B10TP53L3MBTL1NPC1
SCHEMBL31436195 0.70 HPGD (0.62) ADORA2AALDH1A1KDM4EGAAHPGD
SCHEMBL31126851 0.68 ALDH1A1 (0.57) ADORA2AALDH1A1HSD17B10KDM4EGAA
SCHEMBL27989127 0.68 ALDH1A1 (0.61) ADORA2AALDH1A1HSD17B10KDM4EGAA
SCHEMBL13164189 0.68 ALDH1A1 (0.53) ADORA2AALDH1A1HSD17B10KDM4EGAA
SCHEMBL2647891 0.67 ALDH1A1 (0.55) ADORA2AALDH1A1HSD17B10KDM4EGAA
SCHEMBL12629789 0.67 ADORA2A (0.58) ADORA2AALDH1A1HSD17B10KDM4EHPGD
SCHEMBL3580404 0.67 NPC1 (0.52) ALDH1A1KDM4ENPC1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2010-01-28 — — US disclosed
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2010-01-28 — — US disclosed
WO-2008080455-A1 TETRAHYDROBENZOISOXAZOLE - AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2008-07-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN CCNB3, TUBB3, CCNB1 MAPK1 2172/4885ADORA2A 4326/4885PARP1 1727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback